Using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to predict treatment outcomes for advanced hepatocellular carcinoma (HCC) patients who received sorafenib plus tegafur/uracil therapy

収録刊行物

• J Hepatol.

  J Hepatol. 52 (1), S52-, 2010